Decreased plasma clusterin is associated with increased cardiorespiratory fitness as a response to aerobic exercise in older adults with Alzheimer's disease in the FIT‐AD Trial : Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation
: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Decreased plasma clusterin is associated with increased cardiorespiratory fitness as a response to aerobic exercise in older adults with Alzheimer's disease in the FIT‐AD Trial : Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation
:
Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation
Description:
<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>A recent study suggests that plasma clusterin increases with exercise and enhances neurogenesis and reduces neuroinflammation in sedentary mice. The same study also reports a positive association between changes in plasma clusterin and walking distance as response to exercise in older adults with amnestic mild cognitive impairment. The objective of this study is to examine whether aerobic exercise increases plasma clusterin and the correlations between changes in plasma clusterin and cardiorespiratory fitness as response to aerobic exercise in older adults with Alzheimer's disease (AD) in the FIT‐AD trial.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The FIT‐AD Trial is a Phase II randomized controlled trial to investigate the effects of a 6‐month, individualized, moderate‐intensity cycling intervention on cognition in community‐dwelling older adults with mild‐to‐moderate AD. The FIT‐AD subjects were randomly assigned on a 2:1 ratio to cycling and stretching (control) for six months. Fasting blood plasma samples were collected at baseline (n=26), 3 and 6 months. Plasma clusterin concentration was measured by an ELISA kit (R&D Systems, Minneapolis, MN). Symptom‐limited peak cycle‐ergometer test was used to assess VO<jats:sub>2peak</jats:sub>, a gold‐standard measure of cardiorespiratory fitness. Student t's test was used to examine changes in plasma clusterin concentrations between cycling and stretching groups. Linear regression was used to correlate changes in plasma clusterin concentration with changes in VO<jats:sub>2peak</jats:sub>.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>3‐ or 6‐ month changes in plasma clusterin concentrations did not significantly differ between groups However, correlations between 3‐month changes in plasma clusterin (µg/mL) and 3‐ or 6‐month changes in VO<jats:sub>2peak</jats:sub> (L/min) were significant regardless group assignment (beta‐coefficients [standard error (SE)]: ‐ 4.2×10<jats:sup>‐2</jats:sup> [1.8×10<jats:sup>‐2</jats:sup>] L/min change in VO<jats:sub>2peak</jats:sub> per µg/mL change in plasma clusterin and ‐ 4.0×10<jats:sup>‐2</jats:sup> [1.4×10<jats:sup>‐2</jats:sup>], respectively), and in cycling group only (‐ 4.8×10<jats:sup>‐2</jats:sup> [1.6×10<jats:sup>‐2</jats:sup>] and ‐ 3.9×10<jats:sup>‐2</jats:sup> [0.9×10<jats:sup>‐2</jats:sup>], respectively), but not in the stretching (control) group.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>This preliminary study does not support the previous findings. Instead, it reports a significant negative correlation between 3‐month change in plasma clusterin concentration and 3‐ or 6‐ months change in VO<jats:sub>2peak</jats:sub> as response to aerobic exercise with in older adults with AD. Future studies are needed to validate the study findings.</jats:p></jats:sec>